2023 - Research.com Medicine in Spain Leader Award
His primary scientific interests are in Internal medicine, Cardiology, Surgery, Myocardial infarction and Angioplasty. His Internal medicine study combines topics from a wide range of disciplines, such as Diabetes mellitus and Endocrinology. His Surgery study frequently draws connections to adjacent fields such as Revascularization.
His Myocardial infarction research incorporates elements of Stroke and Asymptomatic. His Angioplasty research is multidisciplinary, incorporating perspectives in Coronary arteries and Atherectomy. He focuses mostly in the field of Restenosis, narrowing it down to matters related to Balloon and, in some cases, Clinical endpoint.
Carlos Macaya mainly focuses on Internal medicine, Cardiology, Surgery, Myocardial infarction and Radiology. His work on Angioplasty, Coronary artery disease, Percutaneous coronary intervention and Stenosis as part of general Internal medicine research is frequently linked to In patient, bridging the gap between disciplines. The concepts of his Angioplasty study are interwoven with issues in Lesion, Angina and Balloon.
Carlos Macaya frequently studies issues relating to Percutaneous and Cardiology. His research in Stent, Drug-eluting stent and Complication are components of Surgery. Stent is a component of his Restenosis and Coronary stent studies.
The scientist’s investigation covers issues in Internal medicine, Cardiology, Surgery, Myocardial infarction and In patient. His studies in Stenosis, Heart failure, Propensity score matching, Mortality rate and Valve replacement are all subfields of Internal medicine research. His studies deal with areas such as Multivariate analysis and Dyslipidemia as well as Heart failure.
Revascularization, Conventional PCI, Coronary artery disease, Fractional flow reserve and Transcatheter aortic are among the areas of Cardiology where the researcher is concentrating his efforts. His work carried out in the field of Conventional PCI brings together such families of science as Percutaneous and Percutaneous coronary intervention. His research links Stent with Myocardial infarction.
Carlos Macaya mainly investigates Internal medicine, Cardiology, Stenosis, Percutaneous coronary intervention and Fractional flow reserve. His is doing research in Mace, Percutaneous, Incidence, Propensity score matching and Balloon, both of which are found in Internal medicine. His study in Conventional PCI, Coronary artery disease, Myocardial infarction, Revascularization and Hemodynamics are all subfields of Cardiology.
His Myocardial infarction research includes themes of Intravascular ultrasound, Stent, Clinical endpoint and Diabetes mellitus. His Percutaneous coronary intervention study integrates concerns from other disciplines, such as Platelet aggregation inhibitor, Ticlopidine, Predictive value of tests and Radiology. His work in the fields of Surgery, such as Regimen, overlaps with other areas such as Standard treatment.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A Comparison of Balloon-Expandable-Stent Implantation with Balloon Angioplasty in Patients with Coronary Artery Disease
P. W. Serruys;P. de Jaegere;F. Kiemeneij;C. Macaya.
The New England Journal of Medicine (1994)
Variability in Individual Responsiveness to Clopidogrel: Clinical Implications, Management, and Future Perspectives
Dominick J. Angiolillo;Antonio Fernandez-Ortiz;Esther Bernardo;Fernando Alfonso.
Journal of the American College of Cardiology (2007)
Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial.
Patrick W. J. C. Serruys;Pim de Feyter;Carlos Macaya;Norbert Kokott.
Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II)
Patrick W. Serruys;Ben Van Hout;Hans Bonnier;Victor Legrand.
The Lancet (1998)
Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised controlled trial.
U Sigwart;RH Stables;J Booth;R Erbel.
The Lancet (2002)
Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies.
Raúl Moreno;Cristina Fernández;Rosana Hernández;Fernando Alfonso.
Journal of the American College of Cardiology (2005)
Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial.
Shamir R. Mehta;Jean-François Tanguay;John W. Eikelboom;Sanjit S. Jolly.
The Lancet (2010)
Comparison of Zotarolimus-Eluting and Everolimus-Eluting Coronary Stents
Patrick W Serruys;Sigmund Silber;Scot Garg;Robert Jan van Geuns.
The New England Journal of Medicine (2010)
Platelet Function Profiles in Patients With Type 2 Diabetes and Coronary Artery Disease on Combined Aspirin and Clopidogrel Treatment
Dominick J. Angiolillo;Antonio Fernandez-Ortiz;Esther Bernardo;Celia Ramírez.
Randomized Evaluation of Anticoagulation Versus Antiplatelet Therapy After Coronary Stent Implantation in High-Risk Patients The Multicenter Aspirin and Ticlopidine Trial after Intracoronary Stenting (MATTIS)
Philip Urban;Carlos Macaya;Hans-Jürgen Rupprecht;Ferdinand Kiemeneij.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: